Provided by Tiger Trade Technology Pte. Ltd.

Clover Health Corp

4.30
+0.15003.61%
Post-market: 4.29-0.0085-0.20%17:27 EDT
Volume:3.56M
Turnover:15.29M
Market Cap:2.28B
PE:-104.65
High:4.36
Open:4.16
Low:4.16
Close:4.15
52wk High:5.59
52wk Low:1.58
Shares:529.15M
Float Shares:413.00M
Volume Ratio:1.04
T/O Rate:0.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0411
EPS(LYR):-0.1671
ROE:-5.10%
ROA:-1.77%
PB:6.05
PE(LYR):-25.73

Loading ...

Clover Health Medicare Advantage CEO Jamie Reynoso Sells 2,384 Shares for $11,157.12

Reuters
·
Jul 10

Clover Health to Report Q2 2026 Results After Market Close Aug. 5, Host Webcast Call

Reuters
·
Jul 10

Counterpart Health Unit Says AI Assistant Use Lifts Post-discharge Follow-up Metrics in Whitepaper

Reuters
·
Jul 07

Clover Health Unit Counterpart Releases Analysis Linking Counterpart Assistant Use to Higher HEDIS Care-transition Scores

Reuters
·
Jul 07

Don't Ignore The Insider Selling In Clover Health Investments

Simply Wall St.
·
Jul 07

Clover Health Investments (CLOV) Q1 Beat And Guidance Raise Put Valuation Back In Focus

Simply Wall St.
·
Jul 05

Clover Health wins court ruling prompting CMS to lift 2027 star rating for PPO plan to 4.5

Reuters
·
Jun 19

Clover Health Medicare Advantage CEO Jamie Reynoso disposes of 2,360 shares valued at $11,280.80

Reuters
·
Jun 18

Elite Penny Stocks With Cash Strength Backing Big Growth Stories

Simply Wall St.
·
Jun 17

Clover Health Restructures Leadership After Home-Care CEO Exit

TIPRANKS
·
Jun 17

Clover Health Investments - Brady Priest to Step Down as CEO of Clover Care Services Effective July 3, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 17

Clover Health says Clover Care Services CEO Brady Priest to step down July 3

Reuters
·
Jun 17

Clover Health Stockholders Approve Directors and Executive Pay

TIPRANKS
·
Jun 13

Clover Health shareholders elect three directors at annual meeting

Reuters
·
Jun 13

Clover Health Medicare Advantage CEO Jamie Reynoso disposes of 7,289 shares worth $35,784.99

Reuters
·
Jun 12

Clover Health Investments Is Maintained at Neutral by UBS

Dow Jones
·
Jun 12

UBS Adjusts Clover Health Investments Price Target to $4.75 From $2.75, Maintains Neutral Rating

MT Newswires Live
·
Jun 11

Clover Health price target raised to $4.75 from $2.75 at UBS

TIPRANKS
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Clover Health rises 18.9%

TIPRANKS
·
Jun 11